|
US2015273022A1
|
|
Stabilized ultra-rapid-acting insulin formulations
|
|
US2014357554A1
|
|
Magnesium compositions for modulating the pharmacokinetics and injection site pain of insulin
|
|
US2014336610A1
|
|
Methods and devices for point of use mixing of pharmaceutical formulations
|
|
US2014113856A1
|
|
Magnesium compositions for modulating the pharmacokinetics and pharmacodynamics of insulin and insulin analogs, and injection site pain
|
|
CA2805031A1
|
|
Compositions and methods for modulating the pharmacokinetics and pharmacodynamics of insulin
|
|
WO2011156476A2
|
|
Insulin with a basal release profile
|
|
WO2011143421A1
|
|
Insulin with a stable basal release profile
|
|
WO2011049713A2
|
|
Stabilized glucagon solutions
|
|
US2011097386A1
|
|
Stabilized glucagon solutions
|
|
US2010069292A1
|
|
Insulin with a basal release profile
|
|
US2009175840A1
|
|
Insulin formulations for insulin release as a function of tissue glucose levels
|
|
WO2008124522A2
|
|
Amylin formulations
|
|
US2008096800A1
|
|
Rapid mucosal gel or film insulin compositions
|
|
US2008085298A1
|
|
Rapid Mucosal Gel or Film Insulin Compositions
|
|
US2008090753A1
|
|
Rapid Acting Injectable Insulin Compositions
|
|
CN101454019A
|
|
Rapid acting and long acting insulin combination formulations
|
|
AU2007238114A1
|
|
Rapid acting and long acting insulin combination formulations
|
|
US2008039365A1
|
|
Rapid acting and long acting insulin combination formulations
|
|
US2007191757A1
|
|
Method and Device for Sublingual Drug Delivery Using Iontophoresis
|
|
US2007086952A1
|
|
Rapid Acting and Prolonged Acting Inhalable Insulin Preparations
|
